Andreas Traschütz

sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers

Marc Suárez‐Calvet, Gernot Kleinberger, Miguel Ángel Araque Caballero et al. · EMBO Molecular Medicine · 2016 · 530 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Natural History, Phenotypic Spectrum, and Discriminative Features of Multisystemic RFC1 Disease

Andreas Traschütz, Andrea Cortese, Selina Reich et al. · Neurology · 2021 · 164 citations · Full text

Life Sciences, Genetics, Neurology +17

Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer’s disease

Frederic Brosseron, Andreas Traschütz, Catherine Widmann et al. · Alzheimer s Research & Therapy · 2018 · 117 citations · Full text

Medicine, Neurology, Neuroscience +17

GAA-<i>FGF14</i> ataxia (SCA27B): phenotypic profile, natural history progression and 4-aminopyridine treatment response

Carlo Wilke, David Pellerin, David Mengel et al. · Brain · 2023 · 114 citations

Medicine, Neurology, Neuroscience +13

Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases

Birte Zurek, Kornelia Ellwanger, Lisenka E.L.M. Vissers et al. · European Journal of Human Genetics · 2021 · 103 citations · Full text

Life Sciences, Bioinformatics, Biomedical Informatics +15